The store will not work correctly when cookies are disabled.
N-(2-aminoethyl)-6-nitro-2-phenylquinoline-8-carboxamide
ID: ALA4463549
PubChem CID: 155529896
Max Phase: Preclinical
Molecular Formula: C18H16N4O3
Molecular Weight: 336.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NCCNC(=O)c1cc([N+](=O)[O-])cc2ccc(-c3ccccc3)nc12
Standard InChI: InChI=1S/C18H16N4O3/c19-8-9-20-18(23)15-11-14(22(24)25)10-13-6-7-16(21-17(13)15)12-4-2-1-3-5-12/h1-7,10-11H,8-9,19H2,(H,20,23)
Standard InChI Key: JAKQLWXRJSJHHS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
21.5592 -13.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5581 -14.2041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2661 -14.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2643 -12.9757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9730 -13.3810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9737 -14.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6823 -14.6070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3905 -14.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3858 -13.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6767 -12.9707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0998 -14.6021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0981 -15.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8066 -15.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5136 -15.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5078 -14.5892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7988 -14.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8507 -12.9764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1431 -13.3851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8505 -12.1592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2680 -15.4303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5613 -15.8405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9767 -15.8372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5631 -16.6577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8564 -17.0679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8583 -17.8851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
17 19 1 0
1 17 1 0
3 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
M CHG 2 17 1 19 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.35 | Molecular Weight (Monoisotopic): 336.1222 | AlogP: 2.50 | #Rotatable Bonds: 5 |
Polar Surface Area: 111.15 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.68 | CX Basic pKa: 9.16 | CX LogP: 2.38 | CX LogD: 0.63 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.55 | Np Likeness Score: -1.43 |
References
1. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S.. (2019) Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)., 182 [PMID:31514018] [10.1016/j.ejmech.2019.111649] |